Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 2909
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00839683 | Pharmacokinetic Drug Interaction Study of Dapagliflozin and Valsartan or Simvastatin in Healthy Subjects | ||
| NCT01042977 | Efficacy and Safety in Patients With Type 2 Diabetes Mellitus and Cardiovascular Disease | ||
| NCT00983957 | Study to Assess the Effect of BMS-790052 on the Pharmacokinetics of Ortho Tri-Cyclen® in Healthy Female Subjects | ||
| NCT03601611 | Checkpoint Inhibitor Induced Colitis and Arthritis -Immunomodulation With IL-6 Blockade and Exploration of Disease Mechanisms | ||
| NCT00976495 | Effects of Dapagliflozin on Kidney Function (Glomerular Filtration Rate) in Subjects With Type 2 Diabetes | ||
| NCT00886795 | Safety and Efficacy of Abatacept in Subjects With Chronic Urticaria Who Have Had an Inadequate Response to Anti-histamine Therapy | ||
| NCT05779592 | A Study to Evaluate Nivolumab in Japanese Participants With Muscle-invasive Urothelial Carcinoma | ||
| NCT03566264 | Study of the Sudden Heart Failure Participant Population in the US | ||
| NCT05715463 | Rheumatology-based Adaptive Intervention for Social Determinants and Health Equity | ||
| NCT00284804 | A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's Disease | ||
| NCT03409198 | Phase IIb Study Evaluating Immunogenic Chemotherapy Combined With Ipilimumab and Nivolumab in Breast Cancer | ||
| NCT00924898 | Treatment of Acute HIV With Emtricitabine, Tenofovir and Efavirenz (CID 0805) | ||
| NCT00412984 | Apixaban for the Prevention of Stroke in Subjects With Atrial Fibrillation | ||
| NCT04205409 | Nivolumab for Relapsed, Refractory, or Detectable Disease Post Chimeric Antigen Receptor T-cell Treatment in Patients With Hematologic Malignancies | ||
| NCT06476821 | A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of Single Doses of BMS-986435 (MYK-224) in Healthy Chinese Participants | ||
| NCT02481830 | Effectiveness Study of Nivolumab Compared to Chemotherapy in Patients With Relapsed Small-cell Lung Cancer | ||
| NCT05002569 | A Study to Assess Adjuvant Immunotherapy With Nivolumab Plus Relatlimab Versus Nivolumab Alone After Complete Resection of Stage III-IV Melanoma | ||
| NCT03808441 | CAcTUS - Circulating Tumour DNA Guided Switch | ||
| NCT02401854 | Prevalence of Sub-Clinical Atrial Fibrillation in Elderly Patients With Hypertension, Detected Using an External Loop Recorder | ||
| NCT03829722 | Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer | ||
| NCT00084253 | Study of Boosted Atazanavir (ATV) Versus Non-boosted ATV in Naive Patients | ||
| NCT03143153 | A Study to Evaluate Efficacy in Subjects With Esophageal Cancer Treated With Nivolumab and Ipilimumab or Nivolumab Combined With Fluorouracil Plus Cisplatin Versus Fluorouracil Plus Cisplatin | ||
| NCT01250366 | Study of the Safety & PK of INX-08189 in Chronically-infected HCV, Treatment-naïve Subjects | ||
| NCT03670056 | Ipilimumab and Nivolumab in Recurrent Extensive Stage Small Cell Lung Cancer After Receiving Platinum-based Chemotherapy | ||
| NCT03599622 | An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease | ||
| NCT00203931 | Trial Comparing Cetuximab With Pemetrexed/Cetuximab Therapy for Non-Small Cell Lung Cancer | ||
| NCT02413372 | A Study of BMS-986036 in Subjects With Non-Alcoholic Steatohepatitis (NASH) | ||
| NCT00460954 | A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects | ||
| NCT05939700 | Mavacamten Pregnancy Surveillance Program | ||
| NCT00770302 | Assess Pharmacokinetics, Safety and Tolerability in Healthy Chinese Volunteers After Oral Doses of Saxagliptin | ||
| NCT07063745 | A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion | ||
| NCT00028301 | Atazanavir Versus Lopinavir/Ritonavir (LPV/RTV) in Patients Who Have Not Had Success With Protease Inhibitor-Containing HAART Regimen(s) | ||
| NCT04141254 | Impact of Early Debriefing and Enhanced Educative Components on Direct Oral Anticoagulant Adherence After Venous Thromboembolism. | ||
| NCT03605719 | Dexamethasone, Carfilzomib, & Nivolumab With Pelareorep for Relapsed/Refractory Multiple Myeloma | ||
| NCT06997029 | A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors | ||
| NCT00326729 | Fluid Shifts During Resuscitation: Impacts on Macrocirculation and Microcirculation | ||
| NCT01120457 | First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers | ||
| NCT05558319 | NDMM Patients Candidates for ASCT Comparing Extended VRD Plus vs. Isa-VRD vs. Isa-V-Iberdomide | ||
| NCT03958383 | IT-hu14.18-IL2 With Radiation, Nivolumab and Ipilimumab for Melanoma | ||
| NCT00365612 | Single Tablet Regimen (STR) Simplification Study for HIV-1 Infected Patients | ||
| NCT01885598 | Eliquis Regulatory Post Marketing Surveillance | ||
| NCT04667663 | CPD-DARA in Patients With Relapsed/Refractory Multiple Myeloma. | ||
| NCT03256136 | Nivolumab in Combination With Chemotherapy, or Nivolumab in Combination With Ipilimumab, in Advanced EGFR-Mutant or ALK-Rearranged NSCLC | ||
| NCT00940771 | Equivalence of Boosted Atazanavir Based Regimens and Currently Effective HAART Regimens | ||
| NCT01448044 | Phase III BMS-790052 Add-On to Peg-Interferon Alfa-2a and Ribavirin in Naive Hepatitis C | ||
| NCT00855764 | Late Phase II Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Head and Neck Cancer | ||
| NCT02636036 | Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors | ||
| NCT00501644 | Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer | ||
| NCT01850004 | Open-Label Study Evaluating Dasatinib Therapy Discontinuation in Patients With Chronic Phase Chronic Myeloid Leukemia With Stable Complete Molecular Response | ||
| NCT00258921 | RIAT Registry: Reason for Not Intensifying Antihypertensive Treatment |
